Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Novotech Holdings (NVT HK)
Watchlist
13
Analysis
Health Care
•
China
Largest biotech specialist contract research organization (CRO) in Asia
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Asymchem Laboratories Tianjin
•
23 Nov 2021 23:16
Asymchem Laboratories H Share Listing: On-Demand Science
Asymchem is pre-marketing an H Share listing to raise $1.5 billion, according to press reports. The forward indicators suggest that the near-term...
Arun George
Follow
298 Views
Share
bullish
•
Novotech Holdings
•
01 Oct 2021 11:33
Novotech Health IPO: Forecasts, Peer Comparison and Thoughts on Valuation
Novotech Health is an Asia-Pacific biotech-focused CRO and in this insight, we provide our forecasts for the company’s financials and what could be...
Shifara Samsudeen, ACMA, CGMA
Follow
441 Views
Share
bearish
•
Broncus
•
15 Sep 2021 16:55
Broncus IPO Valuation: Overly Ambitious
Our reverse DCF suggests that the revenues need to grow at a CAGR of 86.3% in order to justify the implied IPO valuation of HK$7.68bn which seems...
Shifara Samsudeen, ACMA, CGMA
Follow
320 Views
Share
bullish
•
Novotech Holdings
•
09 Sep 2021 10:12
Novotech Pre-IPO: PHIP and Valuation Update
We look at the latest update of the Novotech's financials and operation. With new information, we provide a more detailed forecast and valuation.
Ke Yan, CFA, FRM
Follow
239 Views
Share
bullish
•
Novotech Holdings
•
08 Sep 2021 18:48
Novotech Health IPO: Valuation First-Look
Novotech is pre-marketing an HKEx IPO to raise $0.5-1.0 billion. In this note, we present our forecasts and take the first look at Novotech's...
Arun George
Follow
285 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x